The HalfLytely® and Bisacodyl Tablet Bowel Prep Kit is a combination of PEG-3350, an osmotic laxative and bisacodyl, a stimulant laxative, indicated for cleansing of the colon as a preparation for colonoscopy in adults
The HalfLytely and Bisacodyl Tablet Bowel Prep Kit is the only bowel prep approved for use with 2 liters and 1 bisacodyl tablet. After you take this product, it goes through your colon (intestines) and causes you to have liquid stools (bowel movements). This flushes the waste out of your colon. It is important for your colon to be free of waste so that your doctor can clearly examine the lining of your colon during the colonoscopy.
The HalfLytely and Bisacodyl Tablet Bowel Prep Kit is available with flavor packs in cherry, lemon-lime, orange, and pineapple flavors.
Ask your doctor if the HalfLytely and Bisacodyl Tablet Bowel Prep Kit is right for you.
For more information about HalfLytely, click here.
Click here for full Prescribing Information and Medication Guide
Braintree Laboratories Code of Conduct
Braintree Laboratories California Health and Safety Code Statement
HalfLytely® and Bisacodyl Tablet Bowel Prep Kit is a combination of PEG-3350, an osmotic laxative and bisacodyl, a stimulant laxative, indicated for cleansing of the colon as a preparation for colonoscopy in adults. Most common adverse reactions (>3%) are overall discomfort, abdominal fullness, abdominal cramping, nausea, and vomiting. There have been reports of ischemic colitis in patients with use of HalfLytely and 10 mg or 20 mg Bisacodyl Tablets Bowel Prep Kit. Use is contraindicated in the following conditions: gastrointestinal (GI) obstruction, bowel perforation, toxic colitis and toxic megacolon, gastric retention, ileus. Use caution when prescribing for patients with a history of seizures, arrhythmias, impaired gag reflex, regurgitation or aspiration, severe active ulcerative colitis, impaired renal function or patients taking medications that may affect renal function or electrolytes. Patients with impaired water handling who experience severe vomiting should be closely monitored including measurement of electrolytes. Advise all patients to hydrate adequately before, during, and after use.